| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JCONREL.2007.07.015 |
| P698 | PubMed publication ID | 17900737 |
| P50 | author | Charles A. Dinarello | Q834442 |
| P2093 | author name string | Elena Voronov | |
| Ron N Apte | |||
| Smadar Cohen | |||
| Galia Lavi | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biodegradation | Q696715 |
| biodegradable microsphere | Q125660129 | ||
| microsphere | Q1759020 | ||
| P304 | page(s) | 123-130 | |
| P577 | publication date | 2007-08-07 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases | |
| P478 | volume | 123 |
| Q36070769 | Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma. |
| Q35182021 | Curcumin blocks interleukin-1 signaling in chondrosarcoma cells. |
| Q34261494 | Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and upregulation of IL-1Ra in melanoma model |
| Q35221349 | Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma |
| Q51847569 | Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy. |
| Q89725102 | IL-1 Signaling in Tumor Microenvironment |
| Q34911427 | IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines |
| Q38116457 | IL-1Ra and its delivery strategies: inserting the association in perspective. |
| Q43241239 | IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitro |
| Q51795679 | Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model. |
| Q41579564 | Intra-articular interleukin-1 receptor antagonist (IL1-ra) microspheres for posttraumatic osteoarthritis: in vitro biological activity and in vivo disease modifying effect |
| Q37118170 | Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? |
| Q38177270 | Licensing Adaptive Immunity by NOD-Like Receptors |
| Q38826097 | Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin. |
| Q60301375 | NF-κB p65 and p105 implicate in interleukin 1β-mediated COX-2 expression in melanoma cells |
| Q54119984 | Potentiating and synergistic effect of grapefruit juice on the antioxidant and anti-inflammatory activity of aripiprazole against hydrogen peroxide induced oxidative stress in mice. |
| Q38916350 | Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma |
| Q90216405 | Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study |
| Q84830552 | Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials |
| Q38824381 | Synthesis of self-assembled IL-1Ra-presenting nanoparticles for the treatment of osteoarthritis |
| Q37575499 | Targeted drug delivery strategies to treat lung metastasis |
| Q39619917 | The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells |
| Q37683553 | The role IL-1 in tumor-mediated angiogenesis |
| Q33653348 | Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo |
| Q37309171 | Tumor-host interactions: the role of inflammation |
| Q82893743 | [Interleukin-1 and cancer] |
Search more.